市場調查報告書
商品編碼
1466334
生醫材料市場:按類型、分類和應用 - 2024-2030 年全球預測Biomaterials Market by Type (Ceramics, Metallic Biomaterials, Natural Biomaterials), Classification (Bioactive Biomaterials, Bioinert Biomaterials, Bioresorbable Biomaterials), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年生醫材料市場規模為1,672.8億美元,預估2024年將達1,933.8億美元,2030年將達4,641.8億美元,複合年成長率為15.69%。
生醫材料市場包括出於醫療原因(例如診斷、治療和替代操作)與生物系統相互作用的天然或合成材料的開發、生產和行銷。世界人口老化以及隨之而來的慢性病和文明病的增加是市場的主要需求驅動力。此外,醫療植入的日益採用和整容手術數量的增加也促進了市場的成長。開發更複雜和改進的生醫材料的技術進步進一步刺激了市場擴張。此外,醫療保健支出的增加、奈米技術和再生醫學的進步正在推動生醫材料市場的發展。然而,新生醫材料的核准有嚴格的監管要求,由於核准過程耗時且成本高昂,這可能會限制市場成長。此外,生物相容性問題和體內副作用的發生也可能對市場成長構成挑戰。此外,能夠響應生物刺激的智慧生醫材料的開拓以及生醫材料與活細胞和組織的整合以創建更複雜的組織結構預計將為馬蘇創造新的市場成長機會。此外,3D列印技術的創新和個人化醫療領域的成長預計也將為業務成長提供重大機會。
主要市場統計 | |
---|---|
基準年[2023] | 1672.8億美元 |
預測年份 [2024] | 1933.8億美元 |
預測年份 [2030] | 4641.8億美元 |
複合年成長率(%) | 15.69% |
類型: 天然材料的進步以提高功能性生醫材料
陶瓷因其生物相容性、卓越的強度和硬度而常用於整形外科和牙科應用。陶瓷包括氧化鋯等惰性材料和羥磷石灰等生物活性材料。陶瓷因其在承載應用中的穩定性和耐用性而通常受到青睞。金屬生醫材料以其高機械強度而著稱,主要用於整形外科和心血管應用。天然生醫材料源自生物體,因其優異的生物相容性和功能性而被選擇。膠原蛋白、甲殼質、海藻酸和絲等天然生醫材料廣泛用於組織工程和創傷治療應用。聚合生醫材料,包括天然和合成聚合物,是用於各種醫療設備和植入的通用材料。
應用:生醫材料在工業中的多種應用
生醫材料在心血管領域的應用主要集中在人造血管、心臟瓣膜和支架的建構。這項需求源於全球心血管疾病 (CVD) 盛行率的不斷上升,推動了對耐用、生物相容性材料的需求。在牙科領域,生醫材料用於填充物、植入和重組手術。對美容牙科的日益重視和牙科疾病發病率的增加正在推動對生醫材料的需求。神經系統生醫材料用於治療神經損傷、腦腫瘤和神經退化性疾病。對生醫材料的需求是由神經組織的複雜性以及對模擬或支持神經功能的材料的需求所驅動的。在眼科領域,生醫材料用於隱形眼鏡、人工水晶體(IOL) 和角膜植入。生醫材料的整形外科應用包括關節重建、骨移植和骨再生支架,解決肌肉骨骼疾病和運動傷害日益成長的趨勢。整形外科中的生醫材料用於軟組織填充材、植入和重組支架。組織工程應用利用生醫材料來開發人造器官和再生解決方案。創傷治療中的生醫材料可應用於敷料、縫線和皮膚移植。這種需求源自於對更快癒合、降低感染率和改善慢性傷口管理結果的追求。
區域洞察
以美國和加拿大為中心的美洲地區對高階醫療設備和植入中的合成生醫材料表現出濃厚的興趣。美國市場由創新產品開發和廣泛的研究資金推動,包括對醫療應用 3D 列印技術的大量投資。在政府致力於永續醫療保健解決方案的支持下,加拿大對生物聚合物的興趣日益濃厚。歐洲、中東和非洲(Europe、Middle East and Africa)呈現出受監管、經濟和人口因素影響的多樣化客戶需求。歐洲國家因其強大的法規結構而脫穎而出,支持生醫材料的高品質標準和永續性,並在奈米技術和生物可吸收材料方面進行了大量研究。中東醫療基礎設施快速發展,為尖端醫療設備和植入提供了商機。非洲正處於市場開拓的早期階段,但在不斷成長的醫療投資和意識的推動下,它顯示了天然和永續生醫材料的潛力。在包括中國、日本和印度在內的亞太地區,由於人口老化和醫療基礎設施投資增加,對生醫材料的需求正在迅速成長。作為一個規模和成長率都領先的市場,中國是技術創新的中心,一系列生物分解性材料和回收產品的新專利就證明了這一點。日本正專注於醫療應用聚合物和複合材料的前沿研究。隨著製藥和醫療領域的強勁成長,印度對天然材料的需求很高。
FPNV定位矩陣
FPNV定位矩陣對於評估生醫材料市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對生醫材料市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動以及突破性產品開發的見解。
1.生醫材料市場的市場規模與預測是多少?
2.在生醫材料市場預測期內,我們應該考慮投資哪些產品與應用?
3.生醫材料市場的技術趨勢和法規結構是什麼?
4.生醫材料市場主要廠商的市場佔有率為何?
5. 進入生醫材料市場的適當型態和策略手段是什麼?
[192 Pages Report] The Biomaterials Market size was estimated at USD 167.28 billion in 2023 and expected to reach USD 193.38 billion in 2024, at a CAGR 15.69% to reach USD 464.18 billion by 2030.
The biomaterials market includes developing, producing, and marketing natural or synthetic materials that interact with biological systems for medical reasons, such as diagnostic, therapeutic, or replacement operations. An aging global population and the resulting increase in occurrences of chronic and lifestyle diseases are major demand drivers for the market. The rise in the adoption of medical implants and an upswing in the number of cosmetic and plastic surgeries also contribute to market growth. Technological advancements for the development of more sophisticated and improved biomaterials are further stimulating market expansion. Moreover, increased healthcare expenditure and advancements in nanotechnology and regenerative medicine are buoying the biomaterials market. However, strict regulatory requirements for the approval of new biomaterials can lead to lengthy and expensive approval processes, limiting the market growth. Biocompatibility issues and incidences of adverse reactions within the body may also challenge the market growth. Moreover, the development of smart biomaterials that can respond to biological stimuli and the integration of biomaterials with living cells and tissues to produce more complex tissue constructs are expected to create new opportunities for market growth. Innovations in 3D printing technologies and the growing field of personalized medicine are also anticipated to present significant opportunities for business growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 167.28 billion |
Estimated Year [2024] | USD 193.38 billion |
Forecast Year [2030] | USD 464.18 billion |
CAGR (%) | 15.69% |
Type:Advancements in Natural biomaterials for improved functionality
Ceramics are favored for their biocompatibility, exceptional strength, and hardness, as they are commonly used in orthopedic and dental applications. Ceramics include bioinert materials such as zirconia and bioactive materials such as hydroxyapatite. The preference for ceramics is often due to their stability and durability in load-bearing applications. Metallic biomaterials stand out for their high mechanical strength and are predominantly used in orthopedic and cardiovascular applications. Natural biomaterials are derived from living organisms and are selected for their excellent biocompatibility and functionality. Natural biomaterials, including collagen, chitin, alginate, and silk, are extensively used in tissue engineering and wound healing applications. Polymeric biomaterials, including natural and synthetic polymers, are versatile materials used in various medical devices and implants.
Application: Diverse applications of biomaterials across industries
In cardiovascular applications, biomaterials primarily focus on constructing blood vessel prostheses, heart valves, and stents. The need arises from the increasing prevalence of cardiovascular diseases (CVDs) globally, driving demand for durable and biocompatible materials. The dental segment utilizes biomaterials for fillings, implants, and reconstructive surgery. The growing emphasis on aesthetic dentistry and the increasing incidence of dental diseases drive the demand for biomaterials. Biomaterials for the nervous system are utilized in treatments for neural injuries, brain tumors, and neurodegenerative diseases. The demand for biomaterials is propelled by the complexity of neural tissues and the need for materials that mimic or support neural function. In ophthalmology, biomaterials find applications in contact lenses, intraocular lenses (IOLs), and corneal implants, driven by the rising prevalence of visual impairments and a desire for minimally invasive solutions. Orthopedic applications of biomaterials include joint replacements, bone grafts, and scaffolds for bone regeneration, targeting the increasing incidence of musculoskeletal conditions and sports injuries. Biomaterials in plastic surgery are used for soft tissue fillers, implants, and reconstructive scaffolds. Tissue engineering applications harness biomaterials to develop artificial organs and regenerative solutions. Biomaterials in wound healing are applied in dressings, sutures, and skin grafts. The need stems from the quest for faster healing, reduced infection rates, and improved outcomes in chronic wound management.
Regional Insights
The Americas region, primarily the United States and Canada, demonstrates a substantial interest in synthetic biomaterials in high-end medical devices and implants. The U.S. market is driven by innovative product development and extensive research funding, including significant investments in 3D printing technologies for medical applications. Canada showcases a growing interest in biopolymers, supported by government initiatives towards sustainable healthcare solutions. Europe, the Middle East, and Africa (EMEA) exhibit diverse customer needs influenced by regulatory, economic, and demographic factors. European countries stand out for their stringent regulatory frameworks favoring high-quality standards and sustainability in biomaterials, with notable research in nanotechnology and bioresorbable materials. The Middle East, with its rapidly developing healthcare infrastructure, presents opportunities for advanced medical devices and implants. Africa, although in the early stages of market development, shows potential for natural and sustainable biomaterials driven by increasing healthcare investments and awareness. The Asia Pacific region, consisting of China, Japan, India, and other countries, is witnessing a surge in demand for biomaterials due to a growing aging population and increased healthcare infrastructure investments. China, leading in both market size and growth, is a hub for innovation, evident from its series of new patents in biodegradable materials and regenerative products. Japan focuses on advanced research in polymers and composites for healthcare applications. India, with a robust growth in pharmaceutical and healthcare sectors, shows a high demand for natural biomaterials.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biomaterials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomaterials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Ametex Inc., BASF SE, Berkeley Advanced Biomaterials, Braskem, CAM Bioceramics B.V., CDI Products, Celanese Corporation, CeramTec GmbH, CoorsTek, Inc., Corbion NV, Covalon Technologies Ltd., Danimer Scientific, Dentsply Sirona Inc., Eastman Chemical Company, Evonik Industries AG, GELITA AG, Invibio Ltd. by Victrex PLC, Koninklijke DSM N.V., KURARAY Co., Ltd., Medical Device Business Services, Inc. by Johnson & Johnson Services, Inc., Medtronic Plc, Noble Biomaterials, Stryker Corporation, Tissium, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biomaterials Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomaterials Market?
3. What are the technology trends and regulatory frameworks in the Biomaterials Market?
4. What is the market share of the leading vendors in the Biomaterials Market?
5. Which modes and strategic moves are suitable for entering the Biomaterials Market?